Pledge Therapeutics
PrivateLast Round
Follow-on Offering
Apr 17, 2026
Total Funding Raised
$42.9M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Pledge Therapeutics is a biotechnology company that develops small-molecule drugs for challenging disease targets in immuno-oncology and antiviral research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Foundation
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Pledge Therapeutics Comparables
Compare Pledge Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nimbus Therapeutics | 77% | |
| Recursion Pharmaceuticals | 76% | |
| Eli Lilly and Company | 74% | |
Pledge Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Apr 17, 2026 | ||||
| VC Round | Dec 10, 2024 | ||||
| Seed | Apr 3, 2024 | ||||
| Early Funding | Jul 24, 2023 | ||||
| Angel | Nov 8, 2021 | ||||
Series A | Mar 8, 2018 |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
$11M raised in follow-on offering.
- Apr 4, 2026
Grew 17% QoQ, from 24 to 28 employees.
Pledge Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Pledge Therapeutics's valuation, stock price, and market status.